The company has also estimated that it will be ready to submit vaccine data for even younger children – ages 6 months to 5 years – about a month later, in the early November timeframe. If all goes well, that could put vaccine availability for that youngest group around the start of December.

Source: Kids 5-11 appear safely protected by small doses of COVID vaccine, Pfizer says - Ars Technica

Thank goodness!